跳至主要内容
临床试验/CTRI/2024/08/072178
CTRI/2024/08/072178尚未招募3 期

A Randomized Controlled Clinical Trial To Evaluate the Efficacy of Mrduvamana in Kaphapradhana Vatarakta (Gouty Arthritis)

Dr. Anivilla L P Vijaya Swapnika1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月26日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To reduce the signs and symptoms of Kaphapradhana Vatarakta (Gouty ArthritiS) assessed by using CDAI and improve Range of Movements of affected joint assessed by using Goniometer.

研究概览

简要总结

Vatarakta is a disease characterized by Toda, Daha, Kandu, Sopha, Sthambha, Antarbrisha**Arthi, Sphurana and Sparsha Asahishnutwa. Vatarakata is classified into Vata, Pitta, Kapha and Rakta Pradhana varieties other than Utthana and Gambhira varieties. The Kapha Pradhana  variety is characterized by Staimityam, Guruta, Supti, Snigdhatvam and Sheetata apart from Samanya Lakshana of Vatarakta. Gouty arthritis is a monoarticular arthropathy due to the

deposition of uric acid crystals within and around the joints. Gouty Arthritis is characterized by acute monoarthritic of rapid onset, severe pain, extreme tenderness, and marked swelling. The characteristic of the Gouty arthritis may be corelated to Kapha Pradhana Vatarakta in certain stages. Vamana Karma is a prime modality of treatment in treating diseases of Kapha. This is also beneficial in treating diseases where, Kapha is associated with Pitta and Kapha Sthanagatadiseases. Vamana Karma is also performed in healthy persons as seasonal regimen. Mrduvamana is one of the treatment modalities explained in the management of Kaphapradhana Vatarakta. It might remove the rasagata Ama and thus may help in the recovery of the disease. Thus an attempt is made to evaluate the efficacy of Mrduvamana in Kaphapradhana Vatrakta (Gouty Arthritis).

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient fit for Vamana karma.
  • Patients having signs and symptoms of Kaphapradhana Vatarakta (Gouty Arthritis).

排除标准

  • Patients already diagnosed with Rheumatoid arthritis, Osteoarthritis, Osteoarthritis overlapping Gouty arthritis.
  • Patients who are pregnant/ lactating women.

结局指标

主要结局

To reduce the signs and symptoms of Kaphapradhana Vatarakta (Gouty ArthritiS) assessed by using CDAI and improve Range of Movements of affected joint assessed by using Goniometer.

时间窗: Patients from both the groups will be assessed after 15 days.

次要结局

  • To reduce serum uric acid levels(Patients from both the groups will be assessed on day 0 and day 60)

研究者

发起方
Dr. Anivilla L P Vijaya Swapnika
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Anivilla L P Vijaya Swapnika

Sri Jayendra Saraswathi Ayurveda College and Hospital

研究点 (1)

Loading locations...

相似试验